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was a similar trend favoring patency in patients 
who received statins. Also, treatment with a drug-
coated balloon was associated with improved 
patency over a conventional balloon in both pa-
tients receiving statins and those not receiving 
statins. The beneficial effects of statins may be 
additive to those of drug-coated balloons.
In summary, our trial showed that angio-
plasty with a drug-coated balloon maintained 
vessel patency that was superior to that of angio-
plasty with a standard balloon, and it showed 
superiority for a functional end point on the 
Walking Impairment Questionnaire. We agree 
that all patients should receive maximum toler-
ated doses of statins and that data from larger 
studies are lacking to confirm the beneficial 
effects on quality of life and physical function-
ing conferred by angioplasty with a drug-coated 
balloon over conventional angioplasty with a 
standard balloon.
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An Integrated View of Potassium Homeostasis
To the Editor: The review article by Gumz et al. 
(July 2 issue)1 on renal potassium handling fo-
cuses on the cortical collecting duct. We would 
emphasize the emerging recognition of the role 
of the distal convoluted tubule in potassium ho-
meostasis. Dietary potassium was recently shown 
to rapidly (within minutes) inactivate the sodium–
chloride cotransporter in the distal convoluted 
tubule.2 This induced natriuresis and kaliuresis, 
probably by increasing sodium delivery to potas-
sium secretory segments.2 Because aldosterone 
does not mediate this process,2 it is part of the 
feed-forward kaliuretic reflex.1 In another study, 
potassium-induced natriuresis was preserved in a 
model of depletion of extracellular fluid volume 
(which normally results in avid sodium reabsorp-
tion); this indicates the physiologic importance 
of this process.3
The opposite is also true — a low-potassium 
diet activates the sodium–chloride cotransport-
er.4 With such a diet, activity of the sodium–
chloride cotransporter increases through changes 
in cell-membrane voltage, intracellular chloride, 
and kinases that regulate the sodium–chloride 
cotransporter.4 Clinically, the activation of the 
sodium–chloride cotransporter by a low intake 
of dietary potassium may explain the well-
known link with salt-sensitive hypertension.5 In 
summary, the distal convoluted tubule acts as a 
potassium sensor and affects downstream po-
tassium secretion by regulating sodium delivery.
Ewout J. Hoorn, M.D., Ph.D.
Erasmus Medical Center 
Rotterdam, the Netherlands 
e.j.hoorn@erasmusmc.nl
Johannes Loffing, M.D.
University of Zurich 
Zurich, Switzerland
David H. Ellison, M.D.
Oregon Health and Science University 
Portland, OR
No potential conflict of interest relevant to this letter was re-
ported.
1. Gumz ML, Rabinowitz L, Wingo CS. An integrated view of 
potassium homeostasis. N Engl J Med 2015;373:60-72.
2. Sorensen MV, Grossmann S, Roesinger M, et al. Rapid de-
phosphorylation of the renal sodium chloride cotransporter in 
response to oral potassium intake in mice. Kidney Int 2013;83: 
811-24.
3. van der Lubbe N, Moes AD, Rosenbaek LL, et al. K+-induced 
natriuresis is preserved during Na+ depletion and accompanied 
by inhibition of the Na+-Cl- cotransporter. Am J Physiol Renal 
Physiol 2013;305:F1177-F1188.
4. Terker AS, Zhang C, McCormick JA, et al. Potassium modu-
lates electrolyte balance and blood pressure through effects on 
distal cell voltage and chloride. Cell Metab 2015;21:39-50.
5. Mente A, O’Donnell MJ, Rangarajan S, et al. Association of 
urinary sodium and potassium excretion with blood pressure. 
N Engl J Med 2014;371:601-11.
DOI: 10.56/NEJMc1509656
To the Editor: As Gumz et al. correctly state, 
“the healthy kidney has a robust capacity to ex-
crete potassium,” and most people can ingest 
very large quantities of potassium without clini-
cally significant hyperkalemia. However, it is not 
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widely known that excessive ingestion of potas-
sium-rich foods or drinks because of a psychiat-
ric disorder can cause clinically significant hyper-
kalemia in people with healthy kidneys and 
adrenal glands who do not have precipitating 
factors such as diabetes or the use of potassium-
sparing medications. For example, in an adoles-
cent with anorexia nervosa, recurrent hyperkale-
mia occurred with obsessive eating of up to 20 
bananas per day.1 Hyperkalemia developed in 
another patient who had schizophrenia and psy-
chogenic polydipsia when she replaced the water 
in her diet with orange juice.2 Finally, recurrent 
hyperkalemia due to excessive ingestion of dried 
fruits developed in a healthy person, possibly be-
cause of an undiagnosed eating disorder.3
Excessive consumption of potassium-rich foods 
or drinks because of a mental disorder should be 
considered in the differential diagnosis of un-
explained hyperkalemia in otherwise healthy 
people. A careful history regarding the patient’s 
dietary habits should be obtained.3
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To the Editor: Gumz et al. propose that circa-
dian clocks within renal tubular cells are ac-
countable for the kaliuretic effect of aldosterone. 
Yet, another paradoxical phenomenon also con-
tributes to the kaliuretic effects of aldosterone: 
during volume depletion, aldosterone increases 
sodium reabsorption without increasing potas-
sium secretion. Conversely, in hyperkalemic 
states, aldosterone leads to potassium secretion 
without increasing sodium reabsorption. This ef-
fect is mediated through angiotensin II, which 
activates the sodium–chloride cotransporter and 
epithelial sodium channel (ENaC) and inhibits 
the potassium channel (ROMK); this happens 
with no signaling of lysine-deficient protein ki-
nase 4, so there is no increase in potassium ex-
cretion. Furthermore, hyperkalemia without 
volume depletion also occurs because of low angi-
otensin II levels and aldosterone-activated sodium 
reabsorption through the ENaC and potassium 
secretion through ROMK.1
Mohammadreza Ardalan, M.D. 
Samad E.J. Golzari, M.D.
Tabriz University of Medical Sciences 
Tabriz, Iran 
dr.golzari@hotmail.com
No potential conflict of interest relevant to this letter was re-
ported.
1. Arroyo JP, Ronzaud C, Lagnaz D, Staub O, Gamba G. Aldos-
terone paradox: differential regulation of ion transport in distal 
nephron. Physiology (Bethesda) 2011;26:115-23.
DOI: 10.56/NEJMc1509656
The Authors Reply: We agree with Hoorn and 
colleagues that the late distal convoluted neph-
ron participates in potassium homeostasis. This 
is shown in Figure 2 of our article.
Hoorn et al. cite a study by Sorensen et al.1 
that examined the effect of the administration of 
a large potassium load by means of gastric lavage 
that increased the plasma level to approximately 
9 to 11 mmol per liter in sodium–chloride co-
transporter–null and control mice. Sorensen and 
colleagues proposed that this maneuver inhibit-
ed activity of the sodium–chloride cotransporter 
in the early distal convoluted tubule and en-
hanced delivery of sodium to the late distal 
convoluted tubule, the connecting tubule, and 
collecting duct. According to this model, potas-
sium secretion in these latter segments is limit-
ed by sodium delivery, and the shift of sodium 
absorption from the early distal convoluted tu-
bule to these downstream segments explains the 
observed kaliuresis. However, even modest in-
creases in the plasma potassium level that are 
less than the values observed by Sorensen et al. 
have been shown in in vivo microperfusion stud-
ies to directly increase potassium secretion by 
cells in the distal nephron when the luminal 
perfusion rate and sodium delivery are held con-
stant2; thus, an alternative explanation of the 
results of Sorensen et al. merits consideration. 
In addition, because the kaliuretic response oc-
curred before a change in plasma aldosterone, 
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Hoorn et al. propose that this hypothesized kali-
uretic mechanism is a component of the feed-
forward kaliuretic reflex. According to our cur-
rent understanding, however, a feed-forward 
system requires neither a change in the plasma 
aldosterone level nor a change in the plasma 
potassium level.
Pavletic calls attention to an uncommon cause 
of hyperkalemia. The clinician should be able to 
identify it from a careful history.
Ardalan and Golzari interpret our article to 
mean that the circadian clock is responsible for 
a kaliuretic effect of aldosterone. To clarify this 
point, the primary and consistent effect of al-
dosterone on external sodium and potassium 
balance is to promote sodium retention, which 
is observed regardless of the time of day when 
aldosterone is administered. Aldosterone has 
important effects on internal potassium homeo-
stasis by stimulating plasma membrane pump–
leak kinetics and by its action to preserve sodium 
balance and blood pressure. Long-term mineralo-
corticoid stimulation reduces the level of plasma 
potassium in the absence of discernible changes 
in the level of total-body potassium. Conversely, 
the study of Todkar and coworkers3 involving 
aldosterone synthase–null mice shows that ap-
propriate excretion of potassium occurred in the 
complete absence of aldosterone. These mice 
excreted a high physiologic, but not supraphys-
iologic, level of potassium as long as other com-
pensatory systems were preserved.
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Nitroglycerin and Nitric Oxide — A Rondo of Themes  
in Cardiovascular Therapeutics
To the Editor: Steinhorn et al. (July 16 issue)1 
note “anecdotal evidence” of “Sunday heart at-
tacks” caused by withdrawal from nitroglycerin 
in an occupational setting. In reality, since 1882, 
considerable research involving people who 
worked with dynamite has validated such with-
drawal syndromes (e.g., headaches, angina, and 
heart attacks).2 The authors further note that 
sildenafil was originally designed as an antiangi-
nal drug and then was shown to be an effective 
treatment for erectile dysfunction. However, they 
did not voice any concerns about similar effects 
of withdrawal associated with the use of phos-
phodiesterase type 5 inhibitors.
The exponential worldwide sales of longer-
acting cyclic guanosine monophosphate phos-
phodiesterase inhibitors for daily use3 and the 
obvious marketing to younger populations4 sug-
gest that a large proportion of the male popula-
tion may be at risk for withdrawal syndromes 
that were previously noted only in workers with 
long-term exposure to nitroglycerin. Perhaps a 
more appropriate theme for this drug discovery 
may be “bench to bedside to bedroom to grave.”
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